Log In
Print
BCIQ
Print
Print this Print this
 

HPV 16 E6/E7 vaccine

  Manage Alerts
Collapse Summary General Information
Company Etubics Corp.
DescriptionVaccine comprising an adenovirus serotype 5 (Ad5) vector expressing non-oncogenic E6 and E7 antigens of HPV type 16
Molecular Target E6 transforming protein (Human papillomavirus-18) (HpV18gp1) ; E7 transforming protein (Human papillomavirus-16) (HpV16gp2)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat HPV-expressing tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today